Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > REGULATORY
REGULATORY
- Growing Concern Over Return to Brand Names for Generics with Advent of Generic Versions of Combination Drugs
April 16, 2013
- PAFSC’s Second Committee to Review Chugai’s Breast Cancer Drug Pertuzumab on April 25
April 15, 2013
- Supreme Court Rejects Damage Claims in Iressa Suits; Govt, AZ Win 8-Year Battle
April 15, 2013
- Generic Roadmap: CSIMC Bill Payer Rep Says New 60% Target Could “Decelerate” Shift
April 12, 2013
- Cost-Effective Assessment Should Be Reflected in Pricing, Not Used as Criterion for Approval: Healthcare Reps at CSIMC
April 12, 2013
- CSIMC OKs NHI Price Listing of JT’s Anti-HIV Drug Stribild on Emergency Basis
April 11, 2013
- New Flu Act to Take Effect on April 13
April 11, 2013
- Japan Launches Strategic Fund for Drug R&D in Developing World
April 10, 2013
- MHLW Issues Order for Improvement to 5 Generic Companies due to GMP Violations by South Korean Supplier
April 9, 2013
- MHLW Unveils Generic Roadmap, Aims for 60%-Share by FY2017
April 8, 2013
- Expert Council on Cancer Research of MHLW, MEXT, METI to Hold 1st Meeting on April 15 to Discuss Future Cancer Research Strategy
April 8, 2013
- Eisai’s HTA-Savvy Tsuchiya Picked as CSIMC Expert Member
April 5, 2013
- FPMAJ Calls for PAL Amendment to Allow Applications Based on Information in Public Domain for Ultra-Orphan Drugs
April 5, 2013
- HIB Director-General Kikura Calls for Discussions on Pricing Rules for Combination Products Containing OTC Drugs
April 5, 2013
- Astem Pres. Yoshimura Says Wholesalers Should Break Away from Dependence on Long-Listed Drugs
April 4, 2013
- Prime Minister Abe Asks Ministries to Begin Discussions Toward Establishing Japanese Version of NIH
April 2, 2013
- Hodanren Calls for Inclusion of Pharmacies’ Technical Fees in Domestic Drug Prices When Comparing Drug Prices in Japan, US, and Europe
April 1, 2013
- MOF Budget Examiner Hirotsugu Shinkawa Hopes to See New Generic Target Set at Highest Share Achievable at Fastest Pace
March 29, 2013
- MHLW’s Generic Roadmap Compilation in Homestretch
March 29, 2013
- MHLW Committee Calls for New Name for Norvasc or Nolvadex to Prevent Further Prescribing Errors
March 29, 2013
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…